February 27, 2024
Will Frexalimab replace the anti-CD20s?
- /
- /
It is clear to me, and it should be clear to my colleagues, that anti-CD20 therapies have a limited shelf-life…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
February 26, 2024
High incidence, prevalence of pediatric-onset MS in Sweden
- /
by Andrea Lobo, PhD | February 26, 2024 Sweden has a consistently high incidence and prevalence of pediatric-onset multiple sclerosis (PoMS), according to a recently…
February 26, 2024
Dark rim on MS lesions seen with standard MRI may mark activity
- /
- /
- /
Possible way of spotting in clinic rim lesions known to drive progression By Marisa Wexler, MS on 02/26/2024 An imaging…
February 19, 2024
New Free Workshop – Trevor Wicken is doing Hip Flexors
- /
CLICK here to learn more of the exciting Free Workshop…
February 16, 2024
MS trial to test magnetic brain stimulation for overactive bladder
- /
Texas site now enrolling 29 women with MS and urinary tract problems Steve Bryson, PhD avatarby Steve Bryson, PhD |…
February 15, 2024
Press Release: Phase 2 data published in NEJM show potential of frexalimab as high-efficacy therapy in relapsing MS (sanofi.com)
- /
- /
Phase 2 data published in NEJM show potential of frexalimab as high-efficacy therapy in relapsing MS Paris, February 15, 2024. The…
February 15, 2024
Nitric oxide metabolites in blood could aid diagnosis of MS: Study
- /
Molecules were elevated in study of RRMS, PPMS patients by Lindsey Shapiro, PhD | February 13, 2024 Measuring levels of nitric oxide metabolites…
February 9, 2024
MS and Mental Decline: 7 Strategies To Improve Memory and More
- /
Medically reviewed by Amit M. Shelat, D.O. * Written by Brooke Dulka, Ph.D. and Kelly Crumrin Multiple sclerosis (MS) often causes cognitive symptoms such as problems…
February 7, 2024
Confronting the Complicated Challenge of Multiple Sclerosis Pain
- /
For many people with multiple sclerosis (MS), chronic pain is an ever-present companion that hampers their quality of life. Treating…
February 2, 2024
Tysabri biosimilar Tyruko now available in Germany for RRMS
- /
Tyruko (natalizumab), the first biosimilar of Tysabri, is now available in Germany for adults with highly active relapsing-remitting multiple sclerosis (RRMS). As a biosimilar, Tyruko has…
